Qitian C (300061.SZ) traded flat 0 % during a 24 hours period ending at 08:02 PM Central Europe on Tuesday 27th. One Qitian C stock can currently be bought for about CNY 7.14 on popular exchanges. Current supply of Qitian C stocks is 659 mn. Qitian C has a current market capitalization of CNY 4.5 bn and approximately CNY 178.1 mn worth of Qitian C was traded on exchanges in the last 24 hours. Since last month end, Qitian C has traded 0.74 % up. Simple moving average of last 200 days is at CNY 6.87. The highest price of past 52 weeks was recorded at CNY 11.99 on 11/26/2025. 52 weeks low was at CNY 5.56 on 07/21/2026.
Summary of the latest news for Qitian C
Qitian Technology Group Co., Ltd. reported that its first three‑quarter performance remained broadly stable, with revenue slightly up and net profit showing a modest increase. The company continued to refine its product mix and strengthen its core strengths in precision component manufacturing, intelligent acoustic systems, and smart hardware. Investment in research and development and capital projects has maintained a high level of technical capability, supporting the integration of key elements such as optics, sound, and packaging. Analysts note that the firm’s vertical integration model, which unites component production with complete system solutions, is expected to buffer it against market swings and enhance profitability as new smart‑device categories gain traction. Overall, the report signals a steady operational footing and a gradual shift toward higher‑margin offerings.
Here is how related stocks have performed in the past 24 hours:
Lepu Biopharma -H (2157.HK) traded down -10.87 % and now trades at HKD 3.3. Current market capitalisation for Lepu Biopharma -H is HKD 6.3 bn. Current price/earnings ratio for Lepu Biopharma -H is 22.43.
Shanghai Geoharbour Constr (605598.SS) traded flat 0 % and now trades at CNY 21.61. Current market capitalisation for Shanghai Geoharbour Constr is CNY 5.4 bn.
Changzhou Galaxy Century Micro-electronics (688689.SS) traded flat 0 % and now trades at CNY 34. Changzhou Galaxy Century Micro-electronics has a market capitalisation of CNY 5.4 bn. Current price/earnings ratio for Changzhou Galaxy Century Micro-electronics is 41.42. Changzhou Galaxy Century Micro‑Electronics Co., Ltd. has recently reported that its production capacity and revenue performance are improving, with a noted increase in sales during the first half of the year. The company is also pursuing expansion in domestic equipment and material verification, aiming for a higher annual revenue target. While the firm’s financial figures demonstrate growth, it faces ongoing supply‑chain pressures typical of the semiconductor sector, such as extended testing cycles and limited testing capacity. The company’s management highlights a focus on advanced packaging technologies and the broader AI and high‑performance computing markets, where demand is expected to outpace supply. This context underscores the company’s efforts to strengthen its market position amid a rapidly evolving industry landscape.
Fujian Mindong Electric Pw (000993.SZ) traded flat 0 % and now trades at CNY 11.74. Current market capitalisation for Fujian Mindong Electric Pw is CNY 5.4 bn. Current price/earnings ratio for Fujian Mindong Electric Pw is 319.8. FUJIAN MINDONG ELECTRIC PW experienced a notable uptick in its share price during early trading on 27 October 2026, joining a cohort of photovoltaic‑related stocks that saw broad gains. The upward movement coincided with a wider market rally among renewable‑energy and power‑generation firms, reflecting investor optimism about the sector. No specific figures are disclosed, but the company’s performance aligns with a trend of increased valuation across related stocks. Analysts note that the positive momentum may be linked to broader macroeconomic factors, including climate‑related events that could bolster demand for energy infrastructure. Overall, the company’s share price movement suggests a strengthening investor outlook amid a favourable market environment for green‑energy assets.
Beijing Sl Pharmaceutical (002038.SZ) traded flat 0 % and now trades at CNY 5.07. Beijing Sl Pharmaceutical has a market capitalisation of CNY 5.4 bn. Beijing SL Pharmaceutical reported that its 2026 interim shareholders’ meeting was duly convened, with the relevant legal opinions issued by the Beijing Junze Jun Law Firm. The company announced the resolutions passed at the meeting, and provided official documentation of the proceedings. No further operational or financial details were disclosed in the public release.